Atea pharmaceuticals inc.

Major-Pharmaceuticals

AVIR


125 Summer Street
Boston , MA 02110

Executive/
Director

Price

  • Last Close
  • $ 3.51
    $ +0.1 2.93 %
    Jan 3, 2025
  • 52-Week High/Low
  • $4.56 - $2.8
  • YTD
  • 4.5%

  • Trading Volume
  • 10,154
  • Market Cap Full
  • $ 292.9M
  • Shares Outstanding
  • 83.4M
    Nov 7, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - -5% 44.3% -19.5% -30.4% 32.5% 4.5%
Q2 - - - - 4% -63.6% -1.4% 11.6% -15.7% -
Q3 - - - - 8% 63.2% -19.9% -19.8% -1.3% -
Q4 - - - - 34.7% -74.5% -15.5% 1.7% -2.3% -
J F M A M J J A S O N D
2025 4.5% - - - - - - - - - - -
2024 36.4% 3.6% -6.3% -7.9% -1.3% -8.2% 13.5% -1.3% - - - -1.8%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%0%-78%-46%-37%10%4%

Earnings

2019 2020 2021 2022 2023
Q1 - - 0.34 -0.51 -0.43
Q2 - - 0.02 -0.38 -0.34
Q3 - - -0.34 -0.1 -0.40
Q4 - - 1.35 -0.40 -
A -1.4 -0.5 1.4 -1.4 -1.17

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022 2023
Mar - 82.7 83.2 83.3
Jun - 82.7 83.3 83.4
Sep - 82.8 83.3 83.4
Dec 82.6 83.1 83.3 83.4

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - 0.5 0.1 - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 8.7 8.1 - 15 -
Equity multiplier - - - - -